Lakefront Biotherapeutics (LKFT) Inventory (2013 - 2026)

As of Dec 31, 2025, Lakefront Biotherapeutics posted Inventory of $25.41 million, down 54.1% from the prior year.

• Inventory has declined for three consecutive years, with a five-year compound annual growth rate of -9.2% (years ended Dec 2020 to Dec 2025).
• By year, Inventory came in at $55.41 million in the year ended Dec 31, 2024 (-30.4%), $79.6 million in the year ended Dec 31, 2023 (-99.9%), $55.78 billion in the year ended Dec 31, 2022 (+129.2%) and $24.34 billion in the year ended Dec 31, 2021.
• The figure for the quarter ended Mar 31, 2026 ranks as the lowest quarterly Inventory since the quarter ended Mar 31, 2022.
• Year over year, Inventory has now declined in each of the last three quarters, with an average decline of 38.3% over the last six quarters.
• The high point for year-over-year Inventory in five years was the quarter ended Mar 31, 2023 (growth of 169.1%); the low point was the quarter ended Dec 31, 2023 (a decline of 99.9%).
• Per Business Quant data, the three quarters before the quarter ended Mar 31, 2026 came in at $26.18 million (quarter ended Dec 31, 2025), $26.83 million (quarter ended Sep 30, 2025) and $38.25 million (quarter ended Jun 30, 2025).